Clinical Trial Update: Efficacy and Tolerability of Zolmitriptan Nasal Spray [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting efficacy and tolerability of zolmitriptan nasal spray for migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zolmitriptan nasal spray (zolmitriptan)

Snippet

Sponsor: AstraZeneca | Conditions: Migraine | Phase 3 | Status: COMPLETED